Sarah Merritt Fortune (born 1968) is an American immunologist. She is a Full Professor of Immunology and Infectious Diseases in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health.
After earning her MD at the Columbia University College of Physicians and Surgeons,she completed an internship and medical residency in Internal Medicine at Brigham and Women's Hospital. By 2006,Fortune accepted an assistant professor position in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health.[2] Fortune's research focuses on attempting to understand how M. tuberculosis (Mtb) mutates itself to become drug resistant.[3] She collaborated with Harvard professor Megan B. Murray to study how tuberculosis develops drug-resistance mutations.[4] In 2010,Fortune was the recipient of a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.[5]
In 2012,she was appointed the Melvin J. and Geraldine L. Glimcher Associate Professor of Biological Sciences.[3] Three years later,she was promoted to full professor.[2] In 2019,Fortune's research lab,the Harvard Chan School IMPAc-TB Center,received a contract award to help establish three new Immune Mechanisms of Protection Against Mycobacterium tuberculosis (IMPAc-TB) Centers.[6] In 2021,Fortune was elected a Fellow of the American Academy of Microbiology.[7]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
